Patent 10159733 was granted and assigned to Coherus BioSciences on December, 2018 by the United States Patent and Trademark Office.
The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.